益生菌增强非手术牙周治疗效果:随机双盲安慰剂对照试验
AIM: To determine the effect of probiotic lozenges containing Lacticaseibacillus rhamnosus PB01, Latilactobacillus curvatus EB10 and xylitol after non-surgical periodontal treatment (NSPT) on changes in microbial composition.…
要点
- NSPT后服用含PB01、EB10和木糖醇的益生菌含片12周可额外改善BoP%和≥5mm牙周袋数量。
- 益生菌组与Streptococcus sanguinis等有益菌关联,安慰剂组与Treponema socranskii等牙周致病菌关联。
- 短期(12周)内益生菌补充对牙周临床指标有辅助改善作用。
核心结论
- 与安慰剂相比,测试的益生菌补充剂在NSPT后12周内额外减少了牙周炎相关菌种,并更大程度改善了BoP%和PPD≥5mm。
研究设计与样本
- 在基线、第6周和第12周进行微生物采样和临床检查,采用16S测序分析龈下菌群、宏基因组测序分析唾液菌群、 bead-based免疫分析检测唾液细胞因子和蛋白酶。
主要发现
- 第12周时,Treponema socranskii、Selenomonas sputigena、Dialister pneumosintes、Dialister invisus、Anaeroglobus geminatus和Fusobacterium nucleatum与安慰剂组显著关联。
- 第12周时,Streptococcus sanguinis、Neisseria elongata和Neisseria oralis与益生菌组关联。
- 益生菌组的BoP%和PPD≥5mm数量较安慰剂组显著下降更多(p<0.05)。
关键数值与推荐
- 益生菌含片含Lacticaseibacillus rhamnosus PB01、Latilactobacillus curvatus EB10和木糖醇。
- 服用周期为12周,临床和微生物评估在基线、第6周和第12周进行。
- 主要结局为微生物组成变化,次要结局为临床和免疫学影响。
临床怎么用
- 对于II或III期牙周炎患者,在NSPT后短期(12周)辅助使用含PB01、EB10和木糖醇的益生菌含片可能进一步改善BoP%和减少≥5mm牙周袋。
- 益生菌补充可能有助于减少牙周炎相关菌种并增加有益菌种,但需结合临床实际个体化应用。
局限性
- 未报告长期疗效和停药后的持续效果。
- 未报告免疫学指标的具体结果。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIM: To determine the effect of probiotic lozenges containing Lacticaseibacillus rhamnosus PB01, Latilactobacillus curvatus EB10 and xylitol after non-surgical periodontal treatment (NSPT) on changes in microbial composition. The secondary aims were to assess the clinical and immunological impact of probiotic consumption. MATERIALS AND METHODS: Eighty adults with stage II or III periodontitis were enrolled and received NSPT at baseline, followed by a 12-week consumption of probiotics or placebo. Microbial sampling and clinical examination were performed at baseline, Week 6 and Week 12. The subgingival microbiota was analysed using 16S sequencing, the salivary microbiota by metagenomic sequencing and selected cytokines and proteases in saliva by bead-based immunoassay. RESULTS: Sixty-one participants completed the trial (probiotics n = 32, placebo n = 29). At Week 12, Treponema socranskii , Selenomonas sputigena , Dialister pneumosintes , Dialister invisus , Anaeroglobus geminatus and Fusobacterium nucleatum were significantly associated with the placebo group, while Streptococcus sanguinis , Neisseria elongata and Neisseria oralis were associated with the probiotic group. Bleeding on probing percentage (BoP%) and number of periodontal pockets (PPD) ≥ 5 mm decreased significantly more in the probiotic group compared to the placebo group (p < 0.05). CONCLUSION: The tested probiotic supplement resulted in an additional short-term decrease in periodontitis-associated species along with greater improvements in BoP% and PPD ≥ 5 mm 12 weeks post-NSPT, compared to the placebo group.
引用
- Lundtorp-Olsen CM, Andersen SVR, Massarenti L, et al. Probiotics Augment the Effect of Non-Surgical Periodontal Treatment-A Randomised, Double-Blinded, Placebo-Controlled Trial. J Clin Periodontol. 2026. PMID: 42076937. doi:10.1111/jcpe.70136
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。